Victory Capital Management Inc. Has $62.09 Million Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Victory Capital Management Inc. cut its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.8% during the third quarter, HoldingsChannel reports. The firm owned 661,539 shares of the company’s stock after selling 18,911 shares during the period. Victory Capital Management Inc.’s holdings in GE HealthCare Technologies were worth $62,085,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Aptus Capital Advisors LLC grew its position in GE HealthCare Technologies by 17.4% in the third quarter. Aptus Capital Advisors LLC now owns 4,205 shares of the company’s stock valued at $395,000 after acquiring an additional 622 shares during the period. Missouri Trust & Investment Co boosted its stake in GE HealthCare Technologies by 71.2% in the third quarter. Missouri Trust & Investment Co now owns 3,100 shares of the company’s stock valued at $291,000 after acquiring an additional 1,289 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its holdings in GE HealthCare Technologies by 2.3% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,022,396 shares of the company’s stock valued at $95,952,000 after purchasing an additional 23,448 shares during the last quarter. GSA Capital Partners LLP acquired a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $874,000. Finally, Harbour Investments Inc. boosted its position in shares of GE HealthCare Technologies by 4.3% during the third quarter. Harbour Investments Inc. now owns 3,164 shares of the company’s stock worth $297,000 after purchasing an additional 131 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

GEHC has been the topic of a number of research analyst reports. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Evercore ISI increased their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and dropped their price objective for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a report on Monday, September 9th. They set a “neutral” rating and a $90.00 price target for the company. Finally, Stifel Nicolaus raised their target price on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.36.

GE HealthCare Technologies Stock Down 1.5 %

GEHC stock opened at $82.92 on Friday. The stock has a market cap of $37.88 billion, a price-to-earnings ratio of 22.78, a price-to-earnings-growth ratio of 3.05 and a beta of 1.24. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. GE HealthCare Technologies Inc. has a 1-year low of $66.39 and a 1-year high of $94.55. The company’s 50 day moving average is $88.76 and its 200 day moving average is $83.48.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. GE HealthCare Technologies’s revenue for the quarter was up .9% compared to the same quarter last year. During the same period last year, the company earned $0.99 EPS. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.29 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s payout ratio is 3.30%.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.